Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

The community needs you

Question: What are predictions?

Answer

Additional FAQs

Users with extraordinary achievements

Predictions

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€17.00
30.12.25
€59.44
30.12.26
0.00%
30.12.25

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€17.00
30.12.25
€39.91
30.12.26
0.00%
30.12.25

buy
Citigroup Inc.

Start price
Target price
Perf. (%)
€100.58
30.12.25
€110.40
30.12.26
0.00%
30.12.25

buy
iRobot Corp.

Start price
Target price
Perf. (%)
€0.19
30.12.25
-
-
30.12.25

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected

Contest

Compete in Catch the Monkey ...

... and win a prize!

Portfolios of our members

CKDepot
Total
€92,818
Cash
€25,722
Performance (%)
-7.182%
Name Username Total Performance (%) Typ
CKDepot Cashkati  €92,818 -7.182% Large Cap
Prof´s Musterdepot Prof  €107,332 7.332% Large Cap
XY Lokrim  €138,995 38.995% Large Cap
Mein Musterdepot eins Jan1977  €99,691 -0.309% Micro Cap
Test Depot (11.03.2025) AlwaysNegativ  €111,881 11.881% Large Cap

Pros and Cons of these stocks (New Predictions)

Novo Nordisk A/S ADR

WKN: 866931 / Symbol: NVO / Name: Novo Nordisk / Stock / Pharmaceuticals / Large Cap /

Pros
10
Could be very worthwhile Investment >20% year
1
Top 10 in its market
1
Future proof or reliable business model
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!